Important Dates

09 June 2014

On-site registration opens

10 June 2014

Conference opens

Plenary Speakers

Adila Hassim

Co-Founder and Head of Litigation and Legal Services

Section 27

Adila Hassim is Director of Litigation at SECTION27 (which incorporated the AIDS Law Project (ALP) in 2010). She is also a member of the Board of Directors of Corruption Watch.

Adila earned a BA and LLB from the University of Natal, her LLM from the St Louis University School of Law in the United States and she was awarded a JSD cum laude from the University of Notre Dame Law School.

She has clerked for two Constitutional Court judges: Justice Pius Langa and Justice Edwin Cameron. She is a member of the Johannesburg Bar and was admitted as an advocate of the High Court of South Africa in 2003.



 

 

 

Christopher Dye

Director of Health Information in the Office of HIV/AIDS, Tuberculo-sis, Malaria and Neglected Tropical Diseases

Organisation: World Health Organisation

Topic: After 2015: tuberculosis in a new era of health and development

Chris Dye began professional life as an ecologist in the UK, having been educated at the universities of York and Oxford. Until 1996, he was head of the Vector Biology and Epidemiology Unit at the London School of Hygiene and Tropical Medicine, carrying out research on leishmaniasis, malaria and rabies in Africa, Asia and South America.

In 1996, he joined the World Health Organization where he has developed methods for investigating the large-scale dynamics and control of tuberculosis. He is now Director of Health Information in WHO's HIV/AIDS, TB, Malaria and Neglected Tropical Diseases cluster, a Visiting Professor of Zoology at the University of Oxford, a Fellow of The Royal Society and of The UK Academy of Medical Sciences.

 

 

 

 



David G. Russell, Ph.D.

Professor of Infection Biology

Cornell University College of Veterinary Medicine

Topic: Studying the HIV/TB Collision in the Lab and the Clinics

David G. Russell, Ph.D., is the William Kaplan Professor of Infection Biology in the Department of Microbiology and Immunology in the College of Veterinary Medicine, Cornell University. He received his Bachelor of Science from St. Andrews University in Scotland and was awarded a Ph.D. from Imperial College, London University, in 1982.

He has held positions as Group Leader at the Max-Planck-Institüt in Tübingen, Assistant Professor at NYU Medical Center and as Associate and Full Professor in the Department of Molecular Microbiology at Washington University School of Medicine. He served as Chair of the Department of Microbiology and Immunology at the College of Veterinary Medicine, Cornell University from 2000 until 2010.

He has spent his entire career looking at host/pathogen interplay and has authored over 190 publications on the subject, including papers in Science and Nature. Currently he serves on the editorial boards of 4 journals. He won the Burroughs Wellcome Senior Scholar Award in Molecular Parasitology in 1994, and was elected a Fellow of the American Association for the Advancement of Science in 2007. He currently serves on the Bill and Melinda Gates Foundation External Advisory Committee for Global Health.

His research focuses primarily on the interplay between the macrophage and the pathogen Mycobacterium tuberculosis. On the macrophage side of the equation the lab has been developing real-time, functional readouts for the lumenal environment within the phagosome, such as hydrolytic activity and radical production, and how these are modified by immune stimuli and infection. On the bacterial side the group is interested in how the bacterium modifies its intracellular compartment to ensure its survival, and how the bacterium responds metabolically to this changing environment.

This information has been used as the basis of a high-throughput screen to identify small molecules that kill M. tuberculosis inside its host cell. A project pursued in collaboration with Vertex Pharmaceuticals. Finally, at the level of the human host, the lab is studying how human alveolar macrophages respond to M. tuberculosis and how the infection site evolves to either contain the infection or progress to active disease and transmission. More recently his lab has started looking at the role of macrophages as a host cell in HIV infection and HIV/TB co-infections, and as an inflammatory mediator in human cerebral malaria. These human studies are pursued through collaborations with the University of Cape Town, South Africa and the Wellcome Trust Research Laboratories, Blantyre, Malawi. His work is supported by multiple grants from the National Institutes of Health and by Vertex Pharmaceuticals.


Gary Maartens

Chief Specialist Physician and Professor

Groote Schuur Hospital / University of Cape Town

Topic: Preventing TB in people living with HIV

Gary Maartens is a clinical pharmacologist and practicing specialist physician with an infectious disease interest. He has a joint appointment as chief specialist physician and professor at Groote Schuur hospital and University of Cape Town, South Africa, where he is head of the Division of Clinical Pharmacology.

He is a consultant to the largest managed care HIV programme in Africa. His main research interests are HIV-associated tuberculosis, and the safety, effectiveness and cost-effectiveness of antiretroviral therapy in resource-limited settings. He has published over 100 peer reviewed articles, is co-editor of the Handbook of HIV Medicine (Oxford University Press Southern Africa, now in its third edition) and has written several book chapters.

He has been involved in guideline development for both the World Health Organization and the Centers for Disease Control. He is on the editorial boards of Lancet Infectious Diseases, Antiviral Therapy, Cochrane Collaboration (HIV/AIDS Review Group), and the British Journal of Clinical Pharmacology. He is president of the College of Clinical Pharmacologists and on the Colleges of Medicine of South Africa examination board for clinical pharmacology, infectious diseases, and the diploma in HIV medicine.



Gerald Friedland MD

Professor of Medicine and Epidemiology and Public Health

Yale University School of Medicine

Topic: The rise and fall of XDR TB in Tugela Ferry – how we did it

Dr. Friedland currently is Professor of Medicine and Epidemiology and Public Health at the Yale University School of Medicine, in New Haven Connecticut, USA and an Adjunct Professor at the Mailman School of Public Health at Columbia University in New York City. He has served as a Visiting Professor at the Nelson R Mandela School of Medicine and UKZN and as a K-RITH Founding Scientist. Dr. Friedland has focused his career on the prevention, care and treatment of infectious diseases in vulnerable and underserved populations in the US and globally. He has been directly involved in prevention, clinical care and treatment and research with people living with HIV, AIDS and TB since 1981.


Dr Friedland has worked in South Africa since 2000, focusing on the integration of HIV and TB care and treatment in co-infected patients to improve the diagnosis, treatment and outcome of both diseases. With South African colleagues, he has developed, implemented and evaluated projects demonstrating the utility of integration of TB and HIV treatment in reducing morbidity and mortality in both urban and rural settings in KwaZuluNatal. The former has culminated in the CAPRISA SAPiT study and the latter in over a decade of collaborative work with Philanjalo, a South African NGO in Tugela Ferry, KwaZuluNatal. This work has led to the uncovering of the epidemic of extensively resistant (XDR) and multiple drug resistant (MDR) tuberculosis in 2005 among HIV/TB co-infected patients in rural KwaZulu-Natal.


During the past decade, with US and South African colleagues at Philanjalo and UKZN and in collaboration and with the support of the KZN Department of Health and other organizations, joined as the Tugela Ferry Care and Research Collaboration (TF CARES), Dr. Friedland’ s work has focused on defining the epidemiology and outcomes and in developing and testing strategies to reduce transmission and decrease morbidity and mortality in individuals and communities affected by the convergent epidemics of TB, HIV and MDR and XDR TB. He will present the challenges and successes of these efforts.



Keertan Dheda

Professor of Medicine, and Head of the Division of Pulmonology

Groote Schuur Hospital University of Cape Town Lung Institute

Topic: Newer Insights into the pathogenesis, diagnosis and management of MDR and XDR-TB

Keertan Dheda is Professor of Medicine, and Head of the Division of Pulmonology, Department of Medicine, at the University of Cape Town. He has been the recipient of several prestigious awards including the 2013 MRC Gold Scientific Achievement Award and the 2010 International Union Against Tuberculosis and Lung Disease Scientific Award. He has published over 130 peer-reviewed papers including 3 original manuscripts, as study leader, in The Lancet.

His H index is 44 and he holds 3 patents related to new TB diagnostic or infection control technologies. He serves on the editorial boards of several journals including the American Journal of Respiratory and Critical Medicine, Lancet Respiratory Medicine and Scientific Reports (Nature Group of journals).

His main research interests are (i) multi-drug resistant pulmonary infections including TB, (ii) the development and validation of field-friendly diagnostics, and (iii) the immunopathogenesis of TB and other human pulmonary infections. He is involved with the activities of several international academic societies, and serves as co-chair of the LTBI sub-group of the Stop TB Partnership.


Willem Hanekom

Director

South African Tuberculosis Vaccines Initiative

Topic: TB Vaccines

Willem is director of the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town, where he is Professor at the Institute of Infectious Diseases and Molecular Medicine and in the School of Child and Adolescent Health. He is currently on sabbatical at the Bill and Melinda Gates Foundation, as Deputy Director in Global Health, leading the TB vaccine programme.

Willem has authored >140 publications, and has been successful in generating competitive research funding from the NIH, EDCTP and many other agencies. Willem is past president of both the South African Immunological Society and the Federation of African Immunological Societies. He is a regular reviewer for international funding agencies, and an editor/reviewer for many scientific journals. He serves on multiple World Health Organization-affiliated and other international advisory committees in TB vaccine development and translational immunology.

 


Dr Nazir Ismail

Head of the Centre for Tuberculosis incorporating the National TB Reference Laboratory of South Africa

National Health Laboratory Service

Topic: Changes in Tuberculosis Incidence: a time series analysis, South Africa (2004-2012)

Nazir Ismail is the Head of the Centre for Tuberculosis incorporating the National TB Reference Laboratory of South Africa, National Institute of Communicable Diseases/NHLS. He is a medical doctor that specialized in micriobiological pathology passing his fellowship with distinction. He also has 2 diplomas - one in tropical medicine and another a post graduate diploma infection control passing that cum laude. His passion is the study of TB including HIV-TB interactions and the epidemiology of TB. He is a councilor for the Colleges of Medicine South Africa and is a member of several international professional bodies and is a member expert groups both locally and internationally. He has authored and co-authored many peer-reviewed articles.

 

 

 

 

 

 

 

 

Lerole Mametja

Chief Director for TB Control and Management

Organisation: National Department of Health

Topic: The burden of Tuberculosis in South Africa: Are we turning the tide?

Lerole David Mametja is the Chief Director for TB Control and Management in the National Department of Health, South Africa. He has more than 20 years of experience in public health. He was Executive Director of the Health Systems Trust (HST), and NGO supporting public-private partnerships in health. He was also Regional Health Sector Manager for RTI International (linked to University of North Carolina), overseeing its health programme in the Southern African Development Community (SADC), particularly in Mozambique, Lesotho, Swaziland and Namibia. He served as CEO of the Health and Welfare Sector Education Training Authority (HWSETA), an entity that focuses on providing training and skills development opportunities for South Africans. He holds a masters degree in public health (MPH) in Health Policy and Management from Columbia University, New York.

 

 

 

 

 

 

Prof Bavesh Kana

Conference Chair

Head of Research Unit(Wits node of the DST/NRF Centre of Excellence for Biomedi­cal TB Research)

Organisation: University of the Witwatersrand National Health Laboratory Service

Topic: Opening & Welcome Address


Prof. Bavesh Kana is currently the head of the Wits Uni­versity node of the DST/NRF Centre of Excellence for Biomedical TB Research where he is involved in studying tuberculosis with a focus on identifying novel targets for the development of new TB antibiotics to combat MDR/XDR. He received his PhD at Wits and conducted some of his postdoctoral training at the Public Health Research In­stitute in New Jersey. He has also worked in laborato­ries at the University of Pennsylvania, Texas A&M Uni­versity, the Russian Academy of Sciences and Harvard Medical School.
Bavesh has been trained in basic epidemiology at the Columbia University Mailman School of Public Health. He is one of only two scientists in Africa, among the top biomedical sci­entists from 12 countries, to be appointed as an Inter­national Early Career Scientist of the Howard Hughes Medical Institute.

Mr Mmboneni Muofhe

Deputy Director General: Technology Innovation of DST

Previously Chief Director: International Resources at Department of Science and Technology Director: Strategic Partnerships at Department of Science and Technology, Director of Global Projects at Department of Science and Technology. Manager: THRIP at National Research Foundation


Mr. Mmboneni Muofhe is the Deputy Director-General (DDG) for Technology Innovation at the Department of Science and Technology in South Africa. He was previously DDG for International Cooperation and Resources and has held several positions at the Department including being Chief Director: International Resources, Director: Strategic Partnerships and Director: Global Projects. During this period he oversaw South Africa's growing participation in EU Research Funding programmes, lead the mobilization of Official Development Assistance funds to support South Africa science system and the Department’s partnership with Multinational Companies. Mr Muofhe’s earlier working and post-graduate years were mainly on agronomy research, especially agricultural biotechnology. He was a UNESCO Biotechnology Fellow at the Agricultural Research Council in 1997.

Mr Muofhe has extensive experience in management of science, technology and innovation programmes which includes years of coordination, implementation and management of Technology and Human Resources for Industry Programme (THRIP), the South African public-private partnership programme in research and development aimed at improving competitiveness of industry and while at DST, oversaw the implementation of the SA-Finland innovation partnership programmes. Mr. Muofhe's academic achievements include a BSc from the University of Venda, Masters of Science from the University of Cape Town and Masters of Business Administration from the University of Pretoria. Mr Muofhe is currently enrolled for PhD in Technology Commercialisation and Innovation Management at da Vinci Institute looking at the relevance and appropriateness of innovation policies and strategies in developed countries to developing countries

Dr Sibongeseni Dhlomo

MEC of Health:KZN


Dr Sibongiseni Maxwell Dhlomo was born in a serene part of KwaZulu-Natal in a little town in Umbumbulu. He began his illustrious career at Dlangezwa High School and later enrolled at the University of Natal, Durban (1980 – 1985) where he excelled in the field of Medicine.

He later pursued further studies in psychology and sociology. In order to spearhead a holistic treatment and management of clinical processes, he further attained post graduate accolades in public health as well as strategic and project management. His passion for raising the quality of lives of ordinary people and his concern for addressing the pandemic of HIV and Aids and exponential increase of TB and opportunistic diseases motivated him to extend his professional understanding thereby attaining a Postgraduate diploma in HIV and Aids management.

His humble contribution and far reaching implications to ensuring that the people of South Africa and in particular KwaZulu-Natal strive towards attaining freedom led to him joining the people ‘s army, Umkhonto Wesizwe at a very early age. This led to his incarceration in Robben Island.

Dr Dhlomo has practiced as a Medical Practitioner at King Edward Hospital. He has had his own practice at Madadeni Medical Centre in Newcastle.

He has also served as an Academic at the University of KwaZulu-Natal lecturing in Public Health and advising the Vice Chancellor.

His insatiable desire to serve communities was to a degree achieved when he joined the EThekwini Metro Municipality as a Deputy City manager: Health and Social Services.

He paralleled his commitment as a clinician by also contributing immensely to ring fencing programmes with other medical officials around the province, one such very successful operation is the Khanya Africa Volunteer initiative. He serves as a director on the board.

Dr Uvistra Naidoo

Paediatric Clinician

Dept of Health, KZN


Uvistra, a paediatric clinician, is a medical graduate from the University of KZN. He started his career at Groote Schuur Hospital, Cape Town before returning to Durban due to ill health. Though still at a young age, his first hand experience with tuberculosis prompted him to devote his career toward fighting TB. He recently departed the KwaZulu-Natal Research Institute for TB and HIV and currently employed at the Department of Heallth, KZN. He is a Fogarty Global Infectious Diseases scholar and in current paediatric specialization. Uvistra’s research interests include Mtb molecular diagnostics and biomarker detection, with emphasis in the child model.

Dr Fareed Abdullah

CEO

SANAC


Dr Fareed Abdullah is Chief Executive for the South African National AIDS Council SANAC), a position he has held since February 2012. The South African National AIDS Council (SANAC) brings together government, civil society and the private sector to create a collective response to the scourges of HIV, TB and STIs in South Africa. The Council is chaired by the Deputy President of South Africa and meets four times per year. Previously, Dr Abdullah was the Africa Unit Director for the Global Fund to Fight AIDS, Tuberculosis and Malaria and served as director of technical support for the International HIV/AIDS Alliance. From 1994 to 2006, he worked in the Western Cape Provincial Department of Health as deputy director-general and head of the HIV/AIDS program. He led the implementation and scale-up of South Africa's first public sector antiretroviral treatment and mother-to-child HIV transmission prevention efforts. Dr Abdullah received an honorary doctorate from the University of Cape Town for the successful implement of a province-wide ART and PMTCT programme.

Dr Aaron Motsoaledi

Minister of Health

NDOH


Aaron Motsoaledi is South Africa's Minister of Health. He is the Chairman of Hlahlolanang Health and Nutrition Education Project and is a member of the Executive Council of Agriculture, Land and Environment in Limpopo's Provincial Government. Motsoaldi is the Head of the African National Congress' Elections Commission for Limpopo, as well as a member of the Provincial Legislature for the Limpopo Province.

Facebook Feeds

Twitter Feeds